Quintrio
Home

DAIRY PRODUCTS

Lifeway Foods Inc

LWAY

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.

Last trade $18.09
Day change +$0.03 (+0.17%)
Day range $17.44 – $18.37
Volume 87,364
Market cap $273M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$272.86M
Price / earnings
35.89×
Price / book
3.19×
Price / sales
1.08×
EV / sales
1.15×
EV / EBITDA
17.94×

Profitability

Earnings per share
$0.50
Return on assets
5.73%
Return on equity
8.9%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.28×
Current ratio
2.32×
Quick ratio
1.64×
Cash ratio
0.35×

Cash flow

Price / cash flow
52.43×
Price / free cash flow
—
Free cash flow
-$35.24M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for LWAY, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$67.8M$66.89M$63.01M$55.36M$57.14M$53.9M$46.09M$46.93M
Cost of revenue$55.63M$53.87M$45.66M$42.55M$40.74M$38.5M$35.06M$37.12M
Gross profit$12.16M$13.03M$17.35M$12.82M$16.41M$15.4M$11.04M$9.82M
Selling, general and administrative$10.94M$12.29M$10.89M$11.47M$11.23M$9.47M$9.33M$11.05M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$11.08M$12.43M$11.03M$9.05M$11.37M$9.61M$9.46M$9.1M
Operating income$1.09M$600K$6.33M$3.76M$5.04M$5.8M$1.57M$713K
Interest expense-$340K-$215K-$68K-$21K-$21K-$21K-$14K-$3K
Income before taxes$765K$407K$6.26M$3.72M$5.09M$5.91M$4.97M$776K
Income taxes$505K$280K$1.58M$1.18M$1.56M$1.66M$1.43M$936K
Net income$260K$127K$4.67M$2.54M$3.53M$4.25M$3.54M-$160K
Net income attributable to common shareholders$260K$127K$4.67M$2.54M$3.53M$4.25M$3.54M-$160K
EBITDA$2.25M$1.74M$7.38M$4.79M$6.09M$6.76M$2.51M$1.61M
Basic earnings per share$0.02$0.01$0.31$0.17$0.23$0.28$0.23-$0.01
Diluted earnings per share$0.02$0.01$0.30$0.16$0.23$0.28$0.23-$0.01

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
The Motley Fool

Lifeway: 3 Key Takeaways for Long-Term Investors

Lifeway Foods reported record Q3 2026 net sales of $67.8 million but faces margin pressure from elevated milk costs (gross margin at 18%). The company is doubling production capacity at its Waukesha facility by 2027 to meet demand and plans price increases to recover margins toward historical 25%+ levels. Growing GLP-1 adoption and consumer interest in gut health are driving retail shelf expansion.

Benzinga

EDWARD SMOLYANSKY, KEY LWAY SHAREHOLDER: TERMINATION OF POISON PILL MARKS IMPORTANT INFLECTION POINT FOR LIFEWAY SHAREHOLDERS AS GOVERNANCE QUESTIONS MOUNT AHEAD OF THE ELECTION

Edward Smolyansky, largest shareholder and former COO of Lifeway Foods, criticizes the Board's governance, stating the poison pill was only terminated after ISS recommended voting against all directors. He highlights a pattern of reactive governance, the reversal of a board refresh process, and calls for shareholders to vote against incumbent directors at the June 17 Annual Meeting to register dissatisfaction with the Board's conduct.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
May 29, 2013$0.08Jun 28, 2013recurring
May 25, 2012$0.07Jun 29, 2012recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Aug 16, 20062-for-1forward split
Mar 9, 20042-for-1forward split